{
  "id": 3326650,
  "title": "Massive Black Market for Unapproved and Potentially Dangerous Obesity Drug Alarms Doctors",
  "url": "https://urgent.news/2026/08/25/massive-black-market-for-unapproved-and-potentially-dangerous-obesity",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-25T18:54:54.000Z",
  "source": {
    "name": "Futurism",
    "slug": "futurism",
    "url": "https://futurism.com/health-medicine/massive-black-market-obesity-drugs-glp1s-retatrutide"
  },
  "original_language": "en",
  "account": "The popularity of weight-loss drugs, such as GLP-1 receptor agonists, has led to the proliferation of counterfeit versions in the black market, raising serious concerns among doctors and health authorities. One such drug, retatrutide, developed by Eli Lilly, has gained notoriety for its triple-hormone-receptor agonist mechanism, which aims to reduce appetite, regulate insulin levels, and increase calorie burn. Clinical trials have shown promising results, with early participants experiencing an average weight loss of 71.2 pounds. However, the drug has not yet received approval from the FDA, with Eli Lilly not planning to submit its application until 2027. This means that any currently-available version of retatrutide in the black market is potentially dangerous, as it has not undergone rigorous testing.\n\nAmidst the surge in black market sales, one tragic incident occurred in Australia, where a patient suffered severe liver injury after using a counterfeit vial of retatrutide. The liver damage is believed to stem from a \"contaminated batch\" of the unregulated drug, but Australian health authorities are still investigating the exact cause. Marie Sinclair, a liver transplant specialist, warns that users of unregulated peptides may experience serious side effects, including jaundice and severe illness. Despite the risks, Eli Lilly has filed six lawsuits against various med spas, a pharmacy, and other drug vendors for selling counterfeit versions of the drug. John Hertig, a pharmaceutical practice lecturer, emphasizes that the excitement surrounding new therapies should not overshadow the need for rigorous evidence supporting their safety and efficacy. He stresses that patients deserve treatments backed by solid scientific research, not unauthorized products marketed prematurely.",
  "summary": "\"Promising isn't the same as proven.\" The post Massive Black Market for Unapproved and Potentially Dangerous Obesity Drug Alarms Doctors appeared first on Futurism .",
  "key_points": [
    "Black market for unapproved obesity drug retatrutide proliferates",
    "Retatrutide's liver injury case highlights dangers of counterfeit drugs",
    "Eli Lilly not submitting FDA approval until 2027"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}